Advisors Asset Management, Inc. Acadia Pharmaceuticals Inc Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 21,087 shares of ACAD stock, worth $359,955. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,087

Previous 18,588 13.44%

Holding current value

$359,955

Previous $302,000 7.28%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$15.14 - $19.14 $37,834 - $47,830	2,499 Added 13.44%	21,087 $324,000
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $63,333 - $79,795	4,332 Added 30.39%	18,588 $302,000
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $107,078 - $185,746	6,019 Added 73.07%	14,256 $263,000
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $129,376 - $197,800	6,226 Added 309.6%	8,237 $257,000
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $35,795 - $51,582	2,011 New	2,011 $48,000
Q4 2022 Feb 13, 2023	SELL	$14.2 - $18.63 $313,053 - $410,716	-22,046 Reduced 92.1%	1,892 $30,000
Q3 2022 Nov 08, 2022	SELL	$14.11 - $18.27 $7,802 - $10,103	-553 Reduced 2.26%	23,938 $392,000
Q2 2022 Aug 08, 2022	SELL	$13.01 - $27.22 $48,215 - $100,877	-3,706 Reduced 13.14%	24,491 $345,000
Q1 2022 May 17, 2022	SELL	$20.94 - $27.5 $38,990 - $51,205	-1,862 Reduced 6.19%	28,197 $683,000
Q4 2021 Feb 15, 2022	SELL	$16.79 - $27.09 $7,992 - $12,894	-476 Reduced 1.56%	30,059 $702,000
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $3,660 - $5,746	-232 Reduced 0.75%	30,535 $507,000
Q2 2021 Jul 30, 2021	BUY	$19.4 - $27.42 $45,881 - $64,848	2,365 Added 8.33%	30,767 $750,000
Q1 2021 May 07, 2021	BUY	$25.02 - $54.99 $335,618 - $737,635	13,414 Added 89.5%	28,402 $733,000
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $465,024 - $643,487	11,331 Added 309.84%	14,988 $801,000
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $61,695 - $96,558	1,694 Added 86.3%	3,657 $151,000
Q2 2020 Aug 12, 2020	BUY	$39.26 - $52.73 $77,067 - $103,508	1,963 New	1,963 $95,000
Q3 2018 Nov 15, 2018	SELL	$13.03 - $21.81 $128,957 - $215,853	-9,897 Closed	0 $0
Q2 2018 Aug 22, 2018	BUY	$15.07 - $22.34 $147,520 - $218,686	9,789 Added 9063.89%	9,897 $151,000
Q2 2018 Aug 15, 2018	SELL	$15.07 - $22.34 $171,948 - $254,899	-11,410 Reduced 99.06%	108 $151,000
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $12,178 - $17,522	-542 Reduced 4.49%	11,518 $287,000
Q4 2017 Feb 13, 2018	SELL	$26.84 - $39.14 $32,154 - $46,889	-1,198 Reduced 9.04%	12,060 $363,000
Q3 2017 Nov 07, 2017	BUY	$29.49 - $38.37 $390,978 - $508,709	13,258	13,258 $499,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Acadia Pharmaceuticals Inc Transaction History